share_log

Biodexa Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Bigger Capital Fund, LP(9.9%),Bigger Capital Fund GP, LLC(9.9%), etc.

SEC ·  Feb 13 05:35
Summary by Futu AI
On December 21, 2023, Biodexa Pharmaceuticals PLC reported a significant filing with the United States Securities and Exchange Commission. The Schedule 13G filing indicated that Bigger Capital Fund, LP, along with related entities and Michael Bigger, collectively hold a substantial stake in the company. The filing, dated February 12, 2024, shows that Bigger Capital Fund, LP, and its general partner Bigger Capital Fund GP, LLC, as well as District 2 Capital Fund LP and its associated entities, each own 9.9% of Biodexa Pharmaceuticals, with a combination of ordinary shares and shares issuable upon the exercise of warrants. The warrants are subject to a beneficial ownership limitation, which prevents the reporting persons from exceeding a 9.99% ownership stake in the company. The filing also includes a joint filing agreement indicating that the statement is filed on behalf of each reporting person in accordance with SEC regulations.
On December 21, 2023, Biodexa Pharmaceuticals PLC reported a significant filing with the United States Securities and Exchange Commission. The Schedule 13G filing indicated that Bigger Capital Fund, LP, along with related entities and Michael Bigger, collectively hold a substantial stake in the company. The filing, dated February 12, 2024, shows that Bigger Capital Fund, LP, and its general partner Bigger Capital Fund GP, LLC, as well as District 2 Capital Fund LP and its associated entities, each own 9.9% of Biodexa Pharmaceuticals, with a combination of ordinary shares and shares issuable upon the exercise of warrants. The warrants are subject to a beneficial ownership limitation, which prevents the reporting persons from exceeding a 9.99% ownership stake in the company. The filing also includes a joint filing agreement indicating that the statement is filed on behalf of each reporting person in accordance with SEC regulations.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.